• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Research Brief on Benzoic acid,4-[[[4-(hexyloxy)phenyl]methylene]amino]-, butyl ester (CAS: 37177-16-5)

Recent studies on Benzoic acid,4-[[[4-(hexyloxy)phenyl]methylene]amino]-, butyl ester (CAS: 37177-16-5) have highlighted its potential applications in the field of chemical biology and pharmaceutical sciences. This compound, characterized by its unique molecular structure, has been the subject of investigation due to its promising biological activities and potential therapeutic benefits. The following brief provides an overview of the latest research findings, methodologies, and implications related to this compound.

The primary focus of recent research has been on elucidating the compound's mechanism of action and its interactions with biological targets. Studies utilizing advanced spectroscopic techniques, such as NMR and mass spectrometry, have confirmed the structural integrity and stability of Benzoic acid,4-[[[4-(hexyloxy)phenyl]methylene]amino]-, butyl ester under various physiological conditions. These findings are critical for understanding its pharmacokinetic properties and potential as a drug candidate.

In vitro and in vivo experiments have demonstrated the compound's efficacy in modulating specific biochemical pathways. For instance, research has shown that it exhibits significant inhibitory effects on certain enzymes involved in inflammatory responses, suggesting its potential as an anti-inflammatory agent. Additionally, preliminary data indicate that the compound may possess antimicrobial properties, making it a candidate for further exploration in infectious disease therapeutics.

The synthesis and optimization of Benzoic acid,4-[[[4-(hexyloxy)phenyl]methylene]amino]-, butyl ester have also been a key area of investigation. Recent advancements in synthetic chemistry have enabled the production of this compound with higher yields and purity, which is essential for scaling up potential pharmaceutical applications. Researchers have employed green chemistry principles to minimize environmental impact during synthesis, aligning with the growing demand for sustainable drug development practices.

Despite these promising findings, challenges remain in the development of this compound for clinical use. Issues such as bioavailability, toxicity, and long-term stability need to be addressed through further preclinical studies. Collaborative efforts between academic institutions and pharmaceutical companies are underway to overcome these hurdles and accelerate the translation of research findings into practical applications.

In conclusion, Benzoic acid,4-[[[4-(hexyloxy)phenyl]methylene]amino]-, butyl ester (CAS: 37177-16-5) represents a promising candidate in the realm of chemical biology and drug discovery. Continued research and development efforts are expected to unlock its full potential, paving the way for novel therapeutic interventions. This brief underscores the importance of interdisciplinary collaboration and innovative methodologies in advancing the field of chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)